Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2012 /
Metformin's effect on breast cancer

31st Mar - 4th Apr 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 13.04.12
Views: 4684
Rating:

Dr Vuk Stambolic - Ontario Cancer Institute, Toronto, Canada

Dr Stambolic talks about the effects and mechanisms of the drug, metformin, at the AACR 2012 Annual Meeting in Chicago.  

 

It has been discovered that direct effects of metformin use the mTOR pathway, similar to a number of other drugs; however a number of indirect pathways are now being explored through a phase I clinical trial.

Categories:

Breast · Biology · Cytotoxics · AACR 2012

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation